Punjab, April 9 -- Accomplished medical research leader will oversee NCCN programs to advance clinical trials and improve the quality, effectiveness, and accessibility of cancer care.PLYMOUTH MEETING, Pa., April 9, 2026 /PRNewswire/ - Today, the National Comprehensive Cancer Network(R) (NCCN(R))-an alliance of leading cancer centers devoted to patient care, research, and education-announced the selection of Nancy L. Lewis, MD, MBS, FACP, as new Chief Scientific Officer (CSO). Dr. Lewis is an experienced biomedical researcher with expertise in clinical trials for treating solidtumors and hematologic malignancies. She most recently served as Senior Clinical Program Leader for Novartis Pharmaceuticals, after several years as an Associate Profe...